{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:13:07Z","timestamp":1713744787977},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,20]]},"DOI":"10.7759\/cureus.58659","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T02:58:45Z","timestamp":1713668325000},"source":"Crossref","is-referenced-by-count":0,"title":["Drug-Induced Hypersensitivity Syndrome Due to Long-Term Usage of Methotrexate: A Case Report"],"prefix":"10.7759","author":[{"given":"Taichi","family":"Fujimori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiaki","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/all.14061","article-title":"Recent developments and highlights in drug hypersensitivity","volume":"74","author":"Mayorga C","year":"2019","unstructured":"Mayorga C, Fernandez TD, Monta\u00f1ez MI, Moreno E, Torres MJ. Recent developments and highlights in drug hypersensitivity. Allergy. 2019, 74:2368-81. 10.1111\/all.14061","journal-title":"Allergy"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-13-39","article-title":"Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches","volume":"13","author":"Matsuno O","year":"2012","unstructured":"Matsuno O. Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches. Respir Res. 2012, 13:39. 10.1186\/1465-9921-13-39","journal-title":"Respir Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2019.00238","article-title":"Methotrexate-associated pneumonitis and rheumatoid arthritis-interstitial lung disease: current concepts for the diagnosis and treatment","volume":"6","author":"Fragoulis GE","year":"2019","unstructured":"Fragoulis GE, Nikiphorou E, Larsen J, Korsten P, Conway R. Methotrexate-associated pneumonitis and rheumatoid arthritis-interstitial lung disease: current concepts for the diagnosis and treatment. Front Med (Lausanne). 2019, 6:238. 10.3389\/fmed.2019.00238","journal-title":"Front Med (Lausanne)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1843.2003.00420.x","article-title":"The role of interleukin-8 in interstitial pneumonia","volume":"8","author":"Fujimori Y","year":"2003","unstructured":"Fujimori Y, Kataoka M, Tada S, et al.. The role of interleukin-8 in interstitial pneumonia. Respirology. 2003, 8:33-40. 10.1046\/j.1440-1843.2003.00420.x","journal-title":"Respirology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg466","article-title":"Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis","volume":"43","author":"Saravanan V","year":"2004","unstructured":"Saravanan V, Kelly CA. Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis. Rheumatology (Oxford). 2004, 43:143-7. 10.1093\/rheumatology\/keg466","journal-title":"Rheumatology (Oxford)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/94.6.309","article-title":"Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practice","volume":"94","author":"Grove ML","year":"2001","unstructured":"Grove ML, Hassell AB, Hay EM, Shadforth MF. Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practice. QJM. 2001, 94:309-19. 10.1093\/qjmed\/94.6.309","journal-title":"QJM"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.23736\/S0031-0808.16.03260-2","article-title":"Methotrexate and lung disease in rheumatoid arthritis","volume":"59","author":"Conway R","year":"2017","unstructured":"Conway R, Carey JJ. Methotrexate and lung disease in rheumatoid arthritis. Panminerva Med. 2017, 59:33-46. 10.23736\/S0031-0808.16.03260-2","journal-title":"Panminerva Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.201415","article-title":"Methotrexate and cardiovascular disease in patients with rheumatoid arthritis: insights and novel speculations","volume":"48","author":"Kremer JM","year":"2021","unstructured":"Kremer JM. Methotrexate and cardiovascular disease in patients with rheumatoid arthritis: insights and novel speculations. J Rheumatol. 2021, 48:793-5. 10.3899\/jrheum.201415","journal-title":"J Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.02.004","article-title":"Drug-induced hypersensitivity syndrome (DIHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis","volume":"10","author":"Hama N","year":"2022","unstructured":"Hama N, Abe R, Gibson A, Phillips EJ. Drug-induced hypersensitivity syndrome (DIHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis. J Allergy Clin Immunol Pract. 2022, 10:1155-1167.e5. 10.1016\/j.jaip.2022.02.004","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.47.0702","article-title":"Clinical and radiological features of pneumocystis pneumonia in patients with rheumatoid arthritis, in comparison with methotrexate pneumonitis and pneumocystis pneumonia in acquired immunodeficiency syndrome: a multicenter study","volume":"47","author":"Tokuda H","year":"2008","unstructured":"Tokuda H, Sakai F, Yamada H, et al.. Clinical and radiological features of pneumocystis pneumonia in patients with rheumatoid arthritis, in comparison with methotrexate pneumonitis and pneumocystis pneumonia in acquired immunodeficiency syndrome: a multicenter study. Intern Med. 2008, 47:915-23. 10.2169\/internalmedicine.47.0702","journal-title":"Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-017-1333-0","article-title":"Methotrexate-induced hypersensitivity pneumonitis appearing after 30\u00a0years of use: a case report","volume":"11","author":"Salehi M","year":"2017","unstructured":"Salehi M, Miller R, Khaing M. Methotrexate-induced hypersensitivity pneumonitis appearing after 30\u00a0years of use: a case report. J Med Case Rep. 2017, 11:174. 10.1186\/s13256-017-1333-0","journal-title":"J Med Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2006.01.007","article-title":"Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion","volume":"73","author":"Pavy S","year":"2006","unstructured":"Pavy S, Constantin A, Pham T, et al.. Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion. Joint Bone Spine. 2006, 73:388-95. 10.1016\/j.jbspin.2006.01.007","journal-title":"Joint Bone Spine"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2013.09.005","article-title":"Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review","volume":"43","author":"Roubille C","year":"2014","unstructured":"Roubille C, Haraoui B. Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review. Semin Arthritis Rheum. 2014, 43:613-26. 10.1016\/j.semarthrit.2013.09.005","journal-title":"Semin Arthritis Rheum"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-5-199709010-00003","article-title":"Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group","volume":"127","author":"Alarc\u00f3n GS","year":"1997","unstructured":"Alarc\u00f3n GS, Kremer JM, Macaluso M, et al.. Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group. Ann Intern Med. 1997, 127:356-64. 10.7326\/0003-4819-127-5-199709010-00003","journal-title":"Ann Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-010-0280-z","article-title":"Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA","volume":"20","author":"Shidara K","year":"2010","unstructured":"Shidara K, Hoshi D, Inoue E, et al.. Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA. Mod Rheumatol. 2010, 20:280-6. 10.1007\/s10165-010-0280-z","journal-title":"Mod Rheumatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.28357","article-title":"Secondary failure of tocilizumab in treating elderly-onset rheumatoid arthritis with systemic symptoms complicated by diverticulum perforation","volume":"14","author":"Takagi S","year":"2022","unstructured":"Takagi S, Naito Y, Sano C, Ohta R. Secondary failure of tocilizumab in treating elderly-onset rheumatoid arthritis with systemic symptoms complicated by diverticulum perforation. Cureus. 2022, 14:e28357. 10.7759\/cureus.28357","journal-title":"Cureus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.50915","article-title":"Integrating clinical and socio-environmental approaches in managing rheumatoid arthritis with social determinants of health: a case study of an elderly patient in rural Japan","volume":"15","author":"Ohta R","year":"2023","unstructured":"Ohta R, Sano C. Integrating clinical and socio-environmental approaches in managing rheumatoid arthritis with social determinants of health: a case study of an elderly patient in rural Japan. Cureus. 2023, 15:e50915. 10.7759\/cureus.50915","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/248653-drug-induced-hypersensitivity-syndrome-due-to-long-term-usage-of-methotrexate-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T02:58:48Z","timestamp":1713668328000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/248653-drug-induced-hypersensitivity-syndrome-due-to-long-term-usage-of-methotrexate-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,20]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.58659","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,20]]}}}